Chris Blaxland

Interim CEO


Chris Blaxland has over 30 years of experience in small and large companies, in general management, product development, and marketing and aspects of the industry.  His 20 years at GlaxoSmithKline (SmithKline Beecham and SK&F) included worldwide responsibility as Vice President of Strategic Product Development.  Chris is a Principal of Hunter Partners, LLC, a consultancy that provides advice and interim management for early to mid-stage pharmaceutical, biotech and medical device companies.


Chief Executive Officer (Permanent Position to Replace Acting CEO) – Open Position                                ProstaGene is currently seeking a CEO to direct its strategic and tactical planning, to oversee and execute its subcontracted development programs and prostate testing technology, and to provide oversight with the Executive Chairman to its Senior Licensing Executive (see below).

Categories: Management Team People